123 related articles for article (PubMed ID: 14667272)
1. Management of advanced non-small-cell lung cancer in elderly populations.
Lilenbaum R
Clin Lung Cancer; 2003 Nov; 5(3):169-73. PubMed ID: 14667272
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
[TBL] [Abstract][Full Text] [Related]
3. Advanced non-small-cell lung cancer in the elderly.
Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V
Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335
[TBL] [Abstract][Full Text] [Related]
4. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
5. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
Socinski MA
Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
Honecker F; Wedding U; Bokemeyer C;
Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
[TBL] [Abstract][Full Text] [Related]
7. Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
Belani CP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S10-22. PubMed ID: 19780242
[TBL] [Abstract][Full Text] [Related]
8. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
Aggarwal C; Langer CJ
Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
[TBL] [Abstract][Full Text] [Related]
9. Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Kim YH; Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Nishiwaki Y
Respir Med; 2010 Mar; 104(3):434-9. PubMed ID: 19913397
[TBL] [Abstract][Full Text] [Related]
10. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer in the elderly.
Gridelli C; Langer C; Maione P; Rossi A; Schild SE
J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
[TBL] [Abstract][Full Text] [Related]
12. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
Langer F; Helsberg K; Schütte WH; Leschinger MI
Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
[TBL] [Abstract][Full Text] [Related]
13. [Recent topics in chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
15. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
[TBL] [Abstract][Full Text] [Related]
16. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
Lilenbaum RC; List M; Desch C
Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
[TBL] [Abstract][Full Text] [Related]
17. Treatment of elderly patients with stage IV non-small-cell lung cancer.
Weiss J; Stinchcombe TE
Expert Rev Anticancer Ther; 2012 Jan; 12(1):111-20. PubMed ID: 22149437
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
19. The 800-lb gorilla we all ignore: treatment of NSCLC in elderly and PS 2 patients.
Devlin JG; Langer CJ
Clin Adv Hematol Oncol; 2007 Mar; 5(3):216-33. PubMed ID: 17519883
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
Belani CP
Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
